Mechanism of action
Thiamine is converted to its active form, thiamine pyrophosphate (TPP), which serves as an essential cofactor for several key enzymes in carbohydrate and amino acid metabolism.
Key enzymatic roles:
- Pyruvate dehydrogenase complex: converts pyruvate to acetyl-CoA, linking glycolysis to the citric acid cycle
- α-ketoglutarate dehydrogenase: catalyzes a rate-limiting step in the citric acid cycle
- Transketolase: functions in the pentose phosphate pathway, important for NADPH and ribose-5-phosphate production
- Branched-chain α-keto acid dehydrogenase: involved in branched-chain amino acid metabolism
Without adequate thiamine, pyruvate and lactate accumulate, ATP production decreases, and oxidative stress increases. The central and peripheral nervous systems, which rely heavily on aerobic glucose metabolism, are particularly vulnerable to thiamine deficiency. Chronic deficiency leads to structural brain damage, particularly in the mammillary bodies, thalamus, and periaqueductal gray matter—regions classically affected in Wernicke encephalopathy.
- Always give thiamine BEFORE glucose in alcoholics/malnourished patients to prevent Wernicke encephalopathy
- Thiamine pyrophosphate (TPP) is cofactor for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase
- Wernicke triad: confusion, ataxia, ophthalmoplegia (only 10-16% have complete triad)
- Korsakoff syndrome: irreversible anterograde amnesia with confabulation following untreated Wernicke encephalopathy
- Wet beriberi = high-output heart failure; dry beriberi = peripheral neuropathy
- Furosemide increases urinary thiamine losses; chronic use may cause deficiency
- Thiamine deficiency causes lactic acidosis due to impaired pyruvate dehydrogenase activity
- MRI in Wernicke: symmetric T2 hyperintensities in mammillary bodies, thalamus, periaqueductal gray
Indications
Treatment of thiamine deficiency states:
- Wernicke encephalopathy: acute neuropsychiatric syndrome characterized by confusion, ataxia, and ophthalmoplegia (classically nystagmus and lateral rectus palsy); a medical emergency requiring immediate parenteral thiamine
- Korsakoff syndrome: chronic sequel of Wernicke encephalopathy with irreversible anterograde and retrograde amnesia and confabulation
- Beriberi: thiamine deficiency disease with two main forms
- Wet beriberi: high-output heart failure, peripheral edema, tachycardia
- Dry beriberi: peripheral neuropathy with symmetric sensorimotor deficits, particularly in lower extremities
Prophylaxis in high-risk populations:
- Chronic alcohol use disorder (most common cause of deficiency in developed countries)
- Hyperemesis gravidarum
- Prolonged parenteral nutrition without adequate supplementation
- Refeeding syndrome prevention
- Malabsorption syndromes (Crohn disease, celiac disease)
- Dialysis patients
- Patients receiving diuretics (especially furosemide, which increases urinary thiamine loss)
Other uses:
- Maple syrup urine disease (adjunctive therapy in some responsive variants)
- Leigh syndrome (thiamine-responsive variants)
- Critically ill patients with suspected deficiency
Clinical principle: In any patient with altered mental status, suspected alcohol use disorder, or malnutrition, thiamine must be administered before intravenous glucose to avoid precipitating or worsening Wernicke encephalopathy. Glucose administration increases metabolic demand for thiamine as a cofactor, potentially exhausting remaining stores.
Pharmacokinetics
Absorption: Thiamine is absorbed in the duodenum and proximal jejunum via both active transport (at low concentrations) and passive diffusion (at higher concentrations). Absorption is saturable; oral bioavailability decreases with increasing doses. Alcohol impairs intestinal absorption.
Distribution: Water-soluble; distributes widely to tissues with highest concentrations in liver, heart, kidney, and brain. Does not accumulate significantly in body stores; total body stores are approximately 25-30 mg. Crosses the placenta and appears in breast milk.
Metabolism: Phosphorylated intracellularly to thiamine pyrophosphate (active form) by thiamine pyrophosphokinase. Excess thiamine is metabolized in the liver.
Excretion: Primarily renal excretion of unchanged thiamine and metabolites. The kidneys do not retain thiamine efficiently when intake exceeds daily requirements; excess is rapidly excreted in urine. Biological half-life is approximately 9-18 days.
Clinical implications: Because body stores are limited and turnover is rapid, deficiency can develop within 2-3 weeks of inadequate intake. Parenteral administration bypasses absorption barriers and is preferred in acute deficiency states or when oral absorption is unreliable.
Adverse effects
Thiamine is generally very safe with a wide therapeutic margin. Adverse effects are rare.
Hypersensitivity reactions (rare):
- Anaphylaxis: most serious adverse effect, reported primarily with rapid intravenous administration; risk factors include prior sensitization and atopic history
- Pruritus, urticaria
- Angioedema
- Bronchospasm
- Respiratory distress
Local reactions:
- Pain, induration at intramuscular injection site
- Phlebitis with intravenous administration
Other rare effects:
- Nausea
- Restlessness
- Sweating
- Feeling of warmth
- Weakness
Prevention of hypersensitivity: Administer intravenous thiamine slowly (over at least 30 minutes when giving large doses) and have resuscitation equipment available. Intramuscular route may be preferred in non-emergency situations. Intradermal test doses are not reliably predictive and are not routinely recommended.
Toxicity: No established upper limit for oral thiamine due to limited absorption and rapid renal excretion. Excess intake does not cause hypervitaminosis because water-soluble vitamins are not stored in toxic amounts.
Contraindications and warnings
Contraindications:
- Known hypersensitivity to thiamine or any formulation component
Warnings and precautions:
- Anaphylaxis risk: although rare, severe hypersensitivity reactions can occur, particularly with intravenous administration; administer slowly and monitor patients
- Wernicke encephalopathy prevention: always administer thiamine before giving glucose-containing fluids in at-risk patients (alcoholics, malnourished, hyperemesis) to prevent precipitating acute encephalopathy
- Inadequate monotherapy: thiamine deficiency often coexists with other B-vitamin deficiencies; consider multivitamin supplementation, especially in chronic alcoholism
Pregnancy and lactation:
- Pregnancy category A: thiamine is essential during pregnancy and requirements increase; supplementation is safe and recommended when dietary intake is inadequate
- Lactation: compatible with breastfeeding; thiamine is present in breast milk and supplementation may be needed in deficient mothers
Special populations:
- Dialysis patients: thiamine is dialyzable; supplementation may be required
- Elderly: increased risk of deficiency due to decreased intake, absorption, and increased comorbidities
- Genetic disorders: certain genetic variants may require higher doses (e.g., thiamine-responsive maple syrup urine disease, thiamine-responsive megaloblastic anemia)
Drug interactions
Thiamine has relatively few significant drug interactions.
Drugs that decrease thiamine levels or activity:
- Loop diuretics (furosemide): increase urinary thiamine excretion, potentially leading to deficiency with chronic use; monitor and consider supplementation
- Alcohol: impairs thiamine absorption, storage, and phosphorylation to active form; major cause of functional thiamine deficiency
- Antibiotics (trimethoprim, sulfonamides): may interfere with thiamine metabolism in rare cases
Dietary factors:
- Raw fish (thiaminase): certain raw fish and shellfish contain thiaminase, an enzyme that destroys thiamine; cooking inactivates the enzyme
- Tea and coffee: tannins may decrease thiamine absorption when consumed in very large quantities with meals
- Betel nuts: contain anti-thiamine factors
Other interactions:
- Neuromuscular blocking agents: high doses of thiamine may enhance the effects of neuromuscular blockers (theoretical; clinical significance unclear)
- 5-Fluorouracil: thiamine may interfere with antineoplastic activity (theoretical)
Clinical consideration: In hospitalized patients receiving parenteral nutrition, ensure adequate thiamine supplementation, especially before initiating high glucose loads. Patients on chronic diuretic therapy may benefit from routine thiamine assessment or empiric supplementation.
Clinical pearls
High-yield exam concepts:
- Chastek paralysis: thiamine deficiency in animals fed raw fish; illustrates thiaminase activity
- Transketolase activity: red blood cell transketolase activity is the best functional test for thiamine status
- Lactic acidosis: thiamine deficiency can present with unexplained lactic acidosis due to impaired pyruvate metabolism
- Refeeding syndrome: rapid refeeding of malnourished patients can precipitate acute thiamine deficiency; give thiamine before starting nutrition
Classic triad of Wernicke encephalopathy: Only 10-16% of patients present with the complete triad:
- Confusion/altered mental status
- Ataxia
- Ophthalmoplegia (nystagmus, lateral rectus palsy)
Most commonly: Patients present with only confusion or global confusional state. High index of suspicion is essential. Empiric treatment should be started immediately in any at-risk patient; do not wait for confirmation.
Diagnostic approach: Diagnosis is clinical. Laboratory confirmation (decreased RBC transketolase activity, increased erythrocyte transketolase activation by TPP) takes days and should not delay treatment. Brain MRI may show symmetric T2 hyperintensities in mammillary bodies, thalamus, and periaqueductal gray matter, but sensitivity is only 50-60%.
Treatment pearl: The classical Wernicke-Korsakoff syndrome progression can be arrested with prompt thiamine administration, but Korsakoff syndrome (amnesia component) is often irreversible despite treatment. Prevention is therefore critical.
Why thiamine before glucose: Glucose metabolism requires thiamine as a cofactor. Administering glucose to a thiamine-deficient patient increases metabolic demand, potentially depleting remaining stores and precipitating acute Wernicke encephalopathy. This is a high-yield board question.
Alcoholism mechanism: Alcohol causes thiamine deficiency through multiple mechanisms: decreased intake, impaired absorption, decreased hepatic storage, and impaired phosphorylation to active form.
Beriberi types memory aid: "Wet" sounds like "sweat" → cardiac symptoms with fluid overload. "Dry" → neuropathy without edema.
Wernicke triad: CAO - Confusion, Ataxia, Ophthalmoplegia. Thiamine enzymes: PAT - Pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, Transketolase.
Practice questions
1. A 52-year-old man with a history of alcohol use disorder is brought to the emergency department for altered mental status. He has been living on the streets and eating irregularly. On examination, he is confused and disoriented. He has horizontal nystagmus and ataxia. The resident orders intravenous dextrose for suspected hypoglycemia. What should be administered first?
2. A 35-year-old woman who recently emigrated from Southeast Asia presents with progressive bilateral leg weakness, numbness, and tingling in her feet that has worsened over 3 months. She reports eating primarily polished white rice. On examination, she has decreased sensation in a stocking distribution, absent ankle reflexes, and foot drop bilaterally. Laboratory studies show normal glucose and normal B12 level. Which of the following enzyme deficiencies best explains her presentation?
3. A 48-year-old man with alcohol use disorder is admitted for severe malnutrition. After 3 days of high-calorie parenteral nutrition, he develops confusion, ophthalmoplegia, and ataxia. Laboratory studies show unexplained lactic acidosis. An MRI brain shows symmetric hyperintensities in the mammillary bodies and thalami. What pathophysiological mechanism best explains this complication?
Frequently asked questions
How does thiamine work in the body?
Thiamine is converted to thiamine pyrophosphate (TPP), which acts as an essential cofactor for enzymes involved in glucose metabolism, including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase. These enzymes are critical for converting glucose to energy through the citric acid cycle and pentose phosphate pathway. Without adequate thiamine, cells cannot efficiently produce ATP, and the nervous system and heart, which have high energy demands, are particularly vulnerable to dysfunction.
What are the side effects of thiamine?
Thiamine is very safe with rare adverse effects. The most serious but rare side effect is anaphylaxis, which can occur with rapid intravenous administration. Other uncommon reactions include local pain at injection sites, pruritus, urticaria, and mild gastrointestinal upset. Oral thiamine has virtually no side effects because excess is rapidly excreted in urine. Thiamine does not cause toxicity even at high doses due to its water-soluble nature and limited absorption.
What is Wernicke-Korsakoff syndrome?
Wernicke-Korsakoff syndrome is a two-stage neurological disorder caused by severe thiamine deficiency, most commonly seen in chronic alcoholics. Wernicke encephalopathy is the acute phase, presenting with confusion, ataxia, and ophthalmoplegia, though most patients do not have all three findings. If untreated, it progresses to Korsakoff syndrome, characterized by irreversible anterograde amnesia, retrograde amnesia, and confabulation. Immediate thiamine administration can prevent progression, but Korsakoff syndrome often remains permanent despite treatment.
Why must thiamine be given before glucose?
Glucose metabolism requires thiamine as a cofactor for key enzymes like pyruvate dehydrogenase. When glucose is given to a thiamine-deficient patient, it increases metabolic demand for thiamine, potentially exhausting the remaining stores. This can precipitate or worsen Wernicke encephalopathy, causing acute neurological deterioration. In any patient with suspected alcohol use disorder, malnutrition, or altered mental status, thiamine must be administered before or with glucose-containing intravenous fluids to prevent this life-threatening complication.
What is the difference between wet and dry beriberi?
Beriberi is thiamine deficiency disease with two distinct presentations. Wet beriberi primarily affects the cardiovascular system, causing high-output heart failure with peripheral edema, tachycardia, and dilated cardiomyopathy due to impaired cardiac energy metabolism. Dry beriberi affects the peripheral nervous system, causing symmetric sensorimotor polyneuropathy, particularly in the lower extremities, with weakness, paresthesias, and decreased reflexes. Both forms respond to thiamine replacement, but cardiac damage in wet beriberi may be partially irreversible if prolonged.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A11DA01
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.